□ verifies that the product is safe and effective for the target population in receiving countries
□ verifies that the product is programmatically suitable for National Immunization Programmes in developing countries
□ verifies that it meets the programmatic needs and is safe and effective for the population in developed countries
□ other
II. Vaccine portfolio
Please fill out the following table
Vaccine
Produced by your
company
| No. of
Lots produced
Per year
| No. of doses per lot
| Total No. of doses produced in 2010
| Country/ies where
Vaccine is licensed
| Supply
|
Domestic
| International
|
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
